4th Quarter - Report — BOEHRINGER INGELHEIM USA CORPORATION, F… for BOEHRINGER INGELHEIM USA CORPORATION (2017)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

Client

BOEHRINGER INGELHEIM USA CORPORATION

Income

—

Expenses

$750,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report (this page)	Jan 22, 2018	$750,000	Replaced
4th Quarter - Amendment	Sep 14, 2020	$750,000	Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

Animal Health - The Animal Drug User Fee Act of 2003 (ADUFA),

Lobbyist	Covered position, as disclosed
MARY BRIDGET WALSH	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; CMS Rule coding for Biosimilars; IPAB (Independent Payment Advisory Board). Biosimilars and the Part D Coverage Gap Discount.

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act. Resolution expressing support for the designation of November 9, 2017 as "National Diabetes Heart Connection Awareness Day."

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S.Con.Res. 3 (115th), S. 469 (115th)

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Non-Interference; and Drug Pricing. HR. 849 Protecting Seniors' Access to Medicare Act of 2017 (IPAB) Medicare S. Con. Res. 3 - 2017 Budget President's 2018 Budget Blue Print

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S.Con.Res. 3 (115th), H.R. 849 (115th)

Consumer Issues/Safety/Products CSP

Anti-Counterfeiting; S.469 - The Affordable and Safe Drug Importation Act

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 469 (115th)

Accounting ACC

Importation - Affordable and Safe Prescription Drug Importation Act- Sanders

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION